Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
PaperCitations, authors & open-access status
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 412 citations, 2014 year and hybrid oa status.
412
Citations
2014
Year
hybrid
OA Status